英语语法分析

Conclusion Serum activin a may act as a clinical marker of liver cirrhosis in the future.

结论血清激活素a有可能成为新的肝硬化临床参考指标。

Objective To prepare anti-activin receptor-interacting protein 1 (ARIP1) polyclonal antibody.

目的：制备抗激活素受体相互作用蛋白1（ARIP1）抗体并探讨其应用。

The result shown that compound TI13, TI176 and TI179 can enhance activin signal transduction.

结果显示，中药单体TI13、TI176及TI179均可明显增强激活素的信号。